Adma Biologics (ADMA) Prepaid Assets (2011 - 2026)
Adma Biologics' (ADMA) quarterly Prepaid Assets came in at $7.5 million in Q4 2025, down 7.11% YoY from $8.0 million in Q4 2024, and up 7.62% on a QoQ basis from $6.9 million in Q3 2025.
Adma Biologics (ADMA) Prepaid Assets (2011 - 2026) Analysis & Trends
Adma Biologics (ADMA) has 14 years of Prepaid Assets data on file, last reported at $7.5 million in Q4 2025.
- Quarterly Prepaid Assets fell 7.11% year-over-year to $7.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.5 million (down 7.11% YoY) and the FY2025 annual result came in at $7.5 million, down 7.11% from the prior year.
- Prepaid Assets advanced to $7.5 million in Q4 2025, from $6.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $9.5 million in Q3 2024 to a low of $3.7 million in Q1 2024.
- A 5-year average of $6.1 million and a median of $5.5 million in 2022 frame the typical range for Prepaid Assets.
- The widest YoY moves for Prepaid Assets: up 129.59% in 2025, down 27.4% in 2025.
- Tracing ADMA's Prepaid Assets over 5 years: stood at $4.3 million in 2021, then grew by 17.42% to $5.1 million in 2022, then advanced by 4.69% to $5.3 million in 2023, then soared by 50.52% to $8.0 million in 2024, then retreated by 7.11% to $7.5 million in 2025.
- The last three Prepaid Assets figures came in at $7.5 million (Q4 2025), $6.9 million (Q3 2025), and $8.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Adma Biologics | 2.13 Bn | 2.00 Bn | 86.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.64 Mn |
| Dec 31, 2025 | 7.46 Mn |
| Sep 30, 2025 | 6.93 Mn |
| Jun 30, 2025 | 8.09 Mn |
| Mar 31, 2025 | 8.59 Mn |
| Dec 31, 2024 | 8.03 Mn |
| Sep 30, 2024 | 9.55 Mn |
| Jun 30, 2024 | 5.52 Mn |
| Mar 31, 2024 | 3.74 Mn |
| Dec 31, 2023 | 5.33 Mn |
| Sep 30, 2023 | 5.11 Mn |
| Jun 30, 2023 | 5.22 Mn |
| Mar 31, 2023 | 4.38 Mn |
| Dec 31, 2022 | 5.10 Mn |
| Sep 30, 2022 | 5.37 Mn |
| Jun 30, 2022 | 5.40 Mn |
| Mar 31, 2022 | 5.52 Mn |
| Dec 31, 2021 | 4.34 Mn |
| Sep 30, 2021 | 5.86 Mn |
| Jun 30, 2021 | 5.70 Mn |